[Evaluation of indomethacin in non-specific immunotherapy].
D000818:Animals; D001688:Biological Products / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000096:biosynthesis; D008262:Macrophage Activation; D051379:Mice; D010844:Picibanil / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000276:immunology / Q000628:therapy*; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
D001688:Biological Products; D007375:Interleukin-1; D010844:Picibanil; D007213:Indomethacin